Carbon nanotubes as drug delivery vehicles

被引：5

作者：

Arora, Shweta ^{[1
]}

Kumar, Vanish ^{[1
]}

Yadav, Shriniwas ^{[1
]}

Singh, Sukhbir ^{[1
]}

Bhatnagar, Deepika ^{[1
]}

Kaur, Inderpreet ^{[1
]}

机构：

[1] Biomolecular Electronics and Nanotechnology Division (BEND), Central Scientific Instruments Organisation (CSIR-CSIO), Sector-30C, Chandigarh

来源：

Solid State Phenomena | 2015年 / 222卷

关键词：

Biomedical; Cancer; Carbon nanotubes; Drug delivery; Nanomaterials; Toxicity;

D O I：

10.4028/www.scientific.net/SSP.222.145

中图分类号：

学科分类号：

摘要：

Various biomedical applications of nanomaterials have been proposed in the last few years leading to the emergence of a new field in diagnostics and therapeutics. Most of these applications involve the administration of nanoparticles into patients. Carbon Nanotubes are enjoying increasing popularity as building blocks for novel drug delivery systems as well as for bioimaging and biosensing. The recent strategies to functionalize carbon nanotubes have resulted in the generation of biocompatible and water-soluble carbon nanotubes that are well suited for high treatment efficacy and minimum side effects for future cancer therapies with low drug doses. The toxicological profile of such carbon nanotube systems developed as nanomedicines will have to be determined prior to any clinical studies undertaken. © (2015) Trans Tech Publications, Switzerland.

引用

页码：145 / 158

页数：13

共 49 条

[1]

Hanahan D., Weinberg R.A., The Hallmarks of Cancer, Cell, 100, pp. 57-70, (2000)

[2]

Kamb A., Wee S., Lengauer C., Why is cancer drug discovery so difficult?, Nat, Rev. Drug Discov, 6, pp. 115-120, (2007)

[3]

Chambers A.F., Groom A.C., Macdonald I.C., Dissemination and growth of cancer cells in metastatic sites, Nat, Rev. Cancer, 2, pp. 563-572, (2002)

[4]

Chang D.K., Lin C.T., Wu C.H., Wu H.C., A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer, PLOS ONE, 4, pp. 1-11, (2009)

[5]

Tan D.S., Gerlinger M., Teh B.T., Swanton C., Anti-cancer drug resistance: understanding the mechanisms through the use of integrative genomics and functional RNA interference, Eur. J. Cancer, 46, pp. 2166-2177, (2010)

[6]

Persidis A., Cancer multidrug resistance, Nature Biotechnology, 17, pp. 94-95, (1999)

[7]

Shi Kam N.W., Dai H., Carbon nanotubes as intracellular protein transporters: Generality and biological functionality, J. Am. Chem. Soc, 127, pp. 6021-6026, (2005)

[8]

Martin C.R., Kohli P., The emerging field of nanotube biotechnology, Nature, Rev. Drug Discov, 2, pp. 29-37, (2003)

[9]

Kostarelos K., The long and short of carbon nanotube toxicity, Nature Biotechnology, 26, pp. 774-776

[10]

Powers K.W., Palazuelos M., Moudgil B.M., Roberts S.M., Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies, Nanotoxicology, 1, (2007)

← 1 2 3 4 5 →